Titcomb Shawn 13D and 13G filings for ZyVersa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-13 3:11 pm Purchase |
2023-01-13 | 13G | ZyVersa Therapeutics, Inc. ZVSA |
Titcomb Shawn | 2,499 9.630% |
2,499 (New Position) |
Filing |